Press release
Parkinson's Disease Market Development and Research by Acorda Therapeutics, Inc, Amneal Pharmaceuticals LLC , Imugene Limited, Immutep, F. Hoffmann-La Roche Ltd, Osmotica Pharmaceuticals plc
Global Parkinson's Disease Market - Industry Trends - Forecast to 2026
Global Parkinson’s Disease Market is rising gradually to an estimated value of USD 9.7 Billion by 2026 registering a healthy CAGR of 12.2% in the forecast period of 2019-2026. This significant rise in market value can increase research development initiatives to launching novel therapies.
Request for Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-parkinsons-disease-market
Key Players are:
Teva Pharmaceutical Industries Ltd,
GlaxoSmithKline Plc,
Acorda Therapeutics, Inc,
Amneal Pharmaceuticals LLC ,
Imugene Limited,
Immutep,
F. Hoffmann-La Roche Ltd,
Osmotica Pharmaceuticals plc, Vertical Pharmaceuticals, LLC,
Adamas Pharmaceuticals, Inc,
Novartis AG,
Eli Lilly and Company,
AbbVie Inc,
few among others.
Parkinson's Disease Market Definition:
Parkinson’s disease is chronic and progressive neurodegenerative disorders that affects dopamine producing neurons in central nervous system. Parkinson’s disease tends to develops in brain over many years. The patient with Parkinson’s disease experience tremor, slow movement, rigid muscle, impaired posture and balance, loss of automatic movements, slurry speech and others.
According to the Clinical Practice Research Data link summary report 2018, it is identified that there were 145,519 prevalence cases of patient with age 20 and above with Parkinson’s disease in UK seen in the year 2018. The estimation incidence cases were 18,461 in patient aged above 45 or over. This significant rise in patient number acts as a driver for the growth of Parkinson’s disease Market.
Parkinson's Disease Market Drivers
Increase in prevalence rate of parkinson’s disease worldwide
Exposure to certain toxin or change in environment may increase the parkinson’s disease
The launch of new products and research collaboration are the prime strategies to reinforce the market position
Growing in aging population as it affect most commonly in geriatric population
Increase in the rate of R&D initiatives is driving parkinson’s disease drug therapeutics market
Parkinson's Disease Market Restraints
High cost involved in the treatment
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market
Lack of awareness among the patient and physician about parkinson’s disease treatment
View Detailed Table of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-parkinsons-disease-market
Segmentation: Global Parkinson’s Disease Market
Parkinson's Disease Market: By Type
Drug-induced parkinsonism
Vascular parkinsonism
Normal pressure hydrocephalus (NSA)
Corticobasal degeneration (CBD)
Progressive supranuclear palsy (PSP)
Multiple system atrophy (MSA)
Idiopathic Parkinson’s
Others
Parkinson's Disease Market: By Mechanism of Cation type
Dopamine agonists
Monoamine oxidase B (MAO-B) inhibitors
Catechol-O-methyltransferase (COMT) inhibitors
Adenosine A2 receptor antagonist
Parkinson's Disease Market: By Drug Type
Amantadine
Safinamide
Brivaracetam
Pimavanserin
Carbidopa and levodopa
Rivastigmine tartrate
Rotigotine
Ferampanel
Apomorphine hydrochloride
Pramipexole
Others
Parkinson's Disease Market: By Therapy
Medication
Deep brain stimulation
Others
Parkinson's Disease Market: By Route of administration
Oral
Parenteral
Sublingual
Others
Parkinson's Disease Market: By End Users
Hospitals
Homecare
Specialty Clinics
Others
Parkinson's Disease Market: By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Key Developments in the Parkinson's Disease Market:
In February 2018, Osmotica Pharmaceuticals plc received FDA approval for Osmolex ER (amantadine hydrochloride) which is an extended release tablet indicated for the treatment of parkinson’s disease and drug-induced extrapyramidal reactions in adult patients
In August 2017, Adamas Pharmaceuticals, Inc. received FDA approval Gocovri (amantadine) extended release tablet for the treatment of dyskinesia in patients with parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications
Competitive Analysis: Global Parkinson’s Disease Market
Global parkinson’s disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of parkinson’s disease market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global parkinson’s disease market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
View Full Report @ https://www.databridgemarketresearch.com/reports/global-parkinsons-disease-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others. We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Market Development and Research by Acorda Therapeutics, Inc, Amneal Pharmaceuticals LLC , Imugene Limited, Immutep, F. Hoffmann-La Roche Ltd, Osmotica Pharmaceuticals plc here
News-ID: 2091735 • Views: …
More Releases from Data Bridge Market Research
Ophthalmic Ultrasound Imaging Systems Market Size, Share, Trends, Key Drivers, G …
Global Ophthalmic Ultrasound Imaging Systems Market' the new research report adds in Data Bridge Market Research's reports database. This Research Report spread across 329 Page, 53 No of Tables, And 244 No of Figures with summarizing Top companies, with tables and figures. The Ophthalmic Ultrasound Imaging Systems market research report presents a comprehensive study on production capacity, consumption, import and export for all the major regions across the world. By…
Smartphone Sanitizer Market Size, Share, Trends, Key Drivers, Growth and Opportu …
Smartphone Sanitizer Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. The market research and analysis conducted in this report assists clients in forecasting the investment in an emerging market, growth of market share or success of a new product. In addition, this business report endows with a delegate overview of the market where it identifies industry trends, determines brand awareness, potency and insights…
Chemical Dust Suppressants Market Size, Share, Trends, Key Drivers, Growth and O …
Chemical Dust Suppressants Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis. With…
Farm Video Surveillance System Market Size, Share, Trends, Demand, Growth and Co …
Global Farm Video Surveillance System Market study by Data Bridge Market Research provides details about the market dynamics affecting the Farm Video Surveillance System market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Farm Video Surveillance System market analysis report is the high quality report having in-depth market research studies.
For dominating the market or industry…
More Releases for Parkinson
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold
Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global…
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when…
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field.
After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most…
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease.
The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected…
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE
Become knowledgeable about the advancements in surgery
The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and…
